NIH Patents and Patent Applications

This list includes non-provisional and PCT patent filings.

Download a CSV of all Patent records.

For information on patent application codes, country codes, and patent status, see the Patents FAQ.

Tips:
Reset Search to show all records.
Sort columns by clicking on the blue column headers.
The Search function searches across all columns.
To filter results by Lead IC, Country, or Application, type or use the dropdown menu.

Lead IC Reference Number Title Country Patent Application Type Application Number Date Filed Patent Number Date Issued Patent Status Patent PDF
NINDS E-251-2005-0-GB-17 Systems for recovery of motor control via stimulation to a substitute site for an affected area GB EP 11005014.3 Issued
NINDS E-251-2005-0-CH-14 Systems for recovery of motor control via stimulation to a substitute site for an affected area CH EP 11005014.3 Issued
NCI E-201-2010-0-PCT-02 IMMUNOGENIC COMPOSITIONS DERIVED FROM STRUCTURAL ALTERATION OF HIV ENVELOPE PROTEINS PCT PCT PCT/US2011/040887 Expired
NCI E-183-2010-0-EP-05 Compositions and Methods For Treating Inflammatory Conditions EP National Stage 11731584.6 Abandoned
NCI E-183-2010-0-JP-06 Compositions and Methods For Treating Inflammatory Conditions JP National Stage 2013-515561 Abandoned
NCI E-183-2010-0-PCT-02 Compositions and Methods For Treating Inflammatory Conditions PCT PCT PCT/US2011/040952 Expired
NICHD E-201-2011-0-US-01 PEPTIDE PREDICTORS FOR PARAGANGLIOMA AND PHEOCHROMOCYTOMA US 61/498,428 Abandoned
NCI E-183-2010-0-CA-04 Compositions and Methods For Treating Inflammatory Conditions CA National Stage 2802994 Abandoned
NCI E-183-2010-0-AU-03 Compositions and Methods For Treating Inflammatory Conditions AU National Stage 2011268146 Abandoned
NCI E-025-2009-0-NZ-09 Ratio Based Biomarkers And Methods of Use Thereof NZ National Stage 593514 Issued
NCI E-026-2011-0-PCT-02 Diagnosis And Treatment Of Adrenocortical Tumors Using Human MicroRNA-483 PCT PCT PCT/US2011/040648 Expired
NIAID E-323-2005-3-US-09 Influenza Hemagglutinin And Neuraminidase Varians US DIV 13/161,938 Abandoned
NCI E-158-2010-0-EP-04 ANTI-DR4 AGONIST ANTIBODIES EP National Stage 11796455.1 Abandoned
NCI E-158-2010-0-PCT-02 ANTI-DR4 AGONIST ANTIBODIES PCT PCT PCT/US2011/040750 Expired
NCI E-158-2010-0-CA-03 ANTI-DR4 AGONIST ANTIBODIES CA National Stage 2802349 Abandoned
NCI E-196-2011-0-US-01 Use of Frizzled Receptor Expression in Measuring Effect of SFRP ON WNT/BETA-CATENIN Signaling US 61/497,513 Abandoned
NCI E-015-2011-0-US-01 A New Chemical Class Of Antiandrogen For The Treatment Of Castrate-resistant Prostate Cancer US 61/497,129 Abandoned
NCI E-024-2011-1-US-01 COMPOSITIONS AND METHODS FOR ANTIBODIES TARGETING TEMS US 61/496,737 Abandoned
NCI E-024-2011-0-US-01 Conjugates, Antibodies, and Their Use US 61/496,986 Abandoned
NIDA E-087-2002-0-US-10 Methods For Preventing Or Treating Cardiac Arrhythmia US CON 13/158,791 8450325 Expired PDF
NIDDK E-177-2010-0-PCT-02 Thioether Prodrug Compositions As Anti-HIV And Anti-retroviral Agents PCT PCT PCT/US2011/039909 Expired
NIDDK E-177-2010-0-EP-03 Thioether Prodrug Compositions As Anti-HIV And Anti-retroviral Agents EP National Stage 11728731.8 Abandoned
NCI E-174-2011-0-US-01 PSEUDOMONAS EXOTOXIN A WITH LESS IMMUNOGENIC T CELL EPITOPES US 61/495,085 Abandoned
NLM E-107-2010-2-US-02 SELECTIVE OXIDATION OF 5-METHYLCYTOSINE BY TET -FAMILY PROTEINS US National Stage 13/120,861 9115386 Issued PDF
NCI E-091-2002-0-US-05 Zap70 Expression As A Marker for Chronic Lymphocytic Leukemia (CLL)/ Small Lymphocytic Lymphoma (SLL) US DIV 13/155,198 8748114 Expired PDF
NIEHS E-009-2009-0-US-05 Inhibition Of Inter-Alpha-Trypsin Inhibitor For The Treatment of Airway Disease US National Stage 13/133,000 Abandoned
NCI E-200-2011-3-US-02 METHODS OF TREATING ABC-DLBCL USING INHIBITORS OF BRUTON'S TYROSINE KINASE US CIP 13/153,291 Abandoned
NIA E-189-2003-0-US-14 Thalidomide Analogs US DIV 13/153,355 8546430 Abandoned PDF
NCI E-132-2006-2-US-03 Materials And Methods Directed To Asparagine Synthetase And Asparaginase Therapies US DIV 13/151,420 9181552 Abandoned PDF
NIAID E-055-2009-0-US-03 Use Of The ROCK Inhibitor to Sustain Primary Human Keratinocytes In A Proliferative State US National Stage 13/132,391 8637310 Issued PDF
NCI E-048-1997-0-US-30 Methods of Gene Therapy Using NUCLEIC ACID SEQUENCES FOR ATP-BINDING CASSETTE TRANSPORTER US CON 13/151,375 Abandoned
NCI E-170-2010-0-US-04 LINKED PURINE PTERIN HPPK INHIBITORS USEFUL AS ANTIBACTERIAL AGENTS US National Stage 13/704,857 9029344 Abandoned PDF
NCI E-170-2010-0-EP-03 Linked Purine Pterin HPPK Inhibitors Useful As Antibacterial Agents EP National Stage 11796158.1 Abandoned
NCI E-170-2010-0-PCT-02 Linked Purine Pterin HPPK Inhibitors Useful As Antibacterial Agents PCT PCT COMB PCT/US2011/038744 Expired
CC E-036-2009-0-US-03 A Feedback System For Integrating Interventional Planning And Navigation US National Stage 13/131,886 9144461 Issued PDF
NIAID E-252-2012-0-US-01 Kunitz Inhibitor Of Proteases US 61/490,149 Abandoned
NCI E-293-2010-0-US-01 Lipopeptide Inhibitors Of RAS Oncoprotein US 61/489,919 Abandoned
NIAID E-154-2011-0-US-01 Method for Inducing An Immune Response Against Avian, Swine, H1N1, H5N1 Influenza Viruses And Formulations Thereof US 61/490,050 Abandoned
NIAID E-154-2011-1-US-01 Immune Based Treatment For Influenza US 61/490,056 Abandoned
NCI E-082-2014-0-US-01 ALCOHOL-, DIOL-, AND CARBOHYDRATE-SUBSTITUTED INDENOISOQUINOLINES AS TOPOISOMERASE I INHIBITORS US 61/489,900 Expired
NCI E-021-2001-0-US-11 Chromosome 3p21.3 Genes Are Tumor Suppressors US CON 13/114,921 9944951 Expired PDF
NIDCR E-015-2002-3-JP-09 MAMMALIAN SWEET AND AMINO ACID HETERODIMERIC TASTE RECEPTORS JP DIV 2008-260180 Abandoned
NINDS E-206-2011-0-US-01 Use Of Phosphatase Inhibitors or Histone Deacetylase Inhibitors To Treat Gaucher's Disease US 61/489,469 Abandoned
NCI E-215-2008-0-US-05 Gene Expression Signature Of Genomic Instability In Breast Cancer US National Stage 13/119,101 8741574 Abandoned PDF
CC E-063-2006-0-US-02 Hybrid Segmentation Of Anatomical Structure US CON 13/113,849 8340381 Issued PDF
NIAID E-186-2011-0-US-01 Prime-boost Vaccine Strategies Incorporating Lymphocytic Choriomeningitis Virus (LCMV) Vaccines To Protect Against Lentiviral Infection US 61/489,205 Abandoned
NCI E-103-2010-1-EP-02 High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins EP National Stage 11722270.3 Issued
NCI E-103-2010-1-GB-07 High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins GB EP 11722270.3 Issued
NCI E-103-2010-1-DE-05 High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins DE EP 11722270.3 Issued
NCI E-103-2010-1-FR-06 High-Affinity Fully Functional Soluble Single-Domain Human CD4, Antibodies, and Related Fusion Proteins FR EP 11722270.3 Issued